Table 1.
The basic clinical data, imaging characteristics and genetic alterations of PLNTY
| case | Age | Gender | Presentation | Location | Treatment | Outcome | “salt and pepper sign” in T2WI | Calcification | BRAF mutation | Fusion transcripts |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 14 | F | Focal epilepsy | L temporal | GTR | NED | Pos | Pos | Neg | FGFR3-TACC3 |
| 2 | 15 | M | Focal epilepsy | R temporal | GTR | NED | Pos | Pos | BRAF V600E | |
| 3 | 16 | M | Focal epilepsy | R frontal | GTR | NED | Pos | Pos | N/A | |
| 4 [7] | 31 | M | Focal epilepsy | Temporal | N/A | N/A | N/A | N/A | BRAF V600E | |
| 5 [3] | 16 | M | Epilepsy | R temporal | GTR | NED | Pos | Pos in 9/10 cases | BRAF V600E | |
| 6 [3] | 18 | F | Epilepsy | R temporal | STR | Post-op psychosis | Pos | BRAF V600E | ||
| 7 [3] | 23 | F | Epilepsy | R temporal | N/A | N/A | N/A | BRAF V600E | ||
| 8 [3] | 17 | F | Epilepsy | R temporal | GTR | NED | N/A | Neg | FGFR3-TACC3 | |
| 9 [3] | 4 | M | Epilepsy | L temporal | GTR | NED | N/A | Neg | FGFR2-CTNNA3 | |
| 10 [3] | 9 | M | Epilepsy | R frontal | GTR | New seizures after 36 months | Pos | Neg | FGFR2-KIAA1598 | |
| 11 [3] | 10 | M | Dizziness | R occipital | GTR | NED | N/A | Neg | FGFR2-KIAA1598 | |
| 12 [3] | 23 | F | Epilepsy | R temporal | GTR | NED | N/A | Neg | ||
| 13 [3] | 32 | F | Epilepsy | R temporal | GTR | NED | N/A | N/A | ||
| 14 [3] | 24 | F | Visual disturbances | R temporal | GTR | NED | N/A | N/A |
NED No Evidence of Disease, GTR Gross Total Tumor Removal, STR Simple Tumor Removal